The world is teetering on the brink of a public health and economic catastrophe, depending on emergency partnerships between our public and private sectors to develop a successful treatment for the coronavirus. If there was ever a time to be thankful that we have policies in place making that possible, it’s now. But there are those who want to use this crisis to return to the failed policies of the past. Here’s the bottom line: the Bayh-Dole Act works. It allows the private sector to collaborate with universities and federal laboratories, like the National Institutes of Health, knowing that intellectual property they bring into such partnerships will be protected. It also allows academic institutions and federal labs to determine what type of license is best suited to promptly commercialize their inventions.
- Advocating for Ethics-Driven Regulation for Blockchain Technologies
- Panelists Highlight Increased Capital, Importance of Foreign Patents for U.S. Patent Monetization at IPWatchdog LIVE 2022
- Are You Bearish or Bullish on the Patent Market?
- Understanding ‘NNN’ Agreements in China
- Entrepreneur Spotlight: How Ray Young is Fighting Content Theft Encouraged by Big Tech Platforms
- Vidal Bans OpenSky from VLSI IPR in Precedential Director Review Decision
- USPTO Publishes RFC on Continuation and Other Criticized Patent Practices
- Claiming the Solid Form: Balancing Language and Data for Success
- IP Goes Pop! Episode 309: Game Changing Inventions Part 1- the 1800s
- IEEE Approves Pro-Patent Holder Policy Updates